The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Saflutan 15 micrograms/ml, eye drops, solution in single-dose container

PCO Manufacturing Ltd.PPA0465/324/001

Main Information

Trade NameSaflutan 15 micrograms/ml, eye drops, solution in single-dose container
Active SubstancesTafluprost
Dosage FormEye drops, solution in single-dose container
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/324/001

Group Information

ATC CodeS01EE Prostaglandin analogues1)
S01EE05 tafluprost


Licence Issued25/11/2013
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back